DUBLIN, IRELAND, May 01, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), today announced that the company will participate in the following conference in May:
UBS Global Healthcare Conference
- Date: May 22, 2018
- Presentation Time: 9:30 a.m. ET
- Location: New York
The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for the event.
About Horizon Pharma plc
Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians. For us, it’s personal: by living up to our own potential, we are helping others live up to theirs. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter, like us on Facebook or explore career opportunities on LinkedIn.
| Contacts: | |
| Investors: Tina Ventura Senior Vice President, Investor Relations investor-relations@horizonpharma.com | U.S. Media: Geoff Curtis Senior Vice President, Corporate Affairs & Chief Communications Officer media@horizonpharma.com |
| Ruth Venning Executive Director, Investor Relations investor-relations@horizonpharma.com | Ireland Media: Ray Gordon Gordon MRM ray@gordonmrm.ie |